Introduction
Ehlers-Danlos syndromes (EDS) are inherited connective tissue disorders characterized by phenotypic heterogeneity and genetic diversity, showing the common features of skin hyperextensibility, joint hypermobility, and tissue fragility [1] [2] [3] . EDS VIII (OMIM 130080) was first reported in 1972 in a patient diagnosed with early severe periodontitis, skin fragility, and abnormal scarring, which were subsequently recognized as symptoms of a distinct EDS subtype inherited an autosomal dominant manner in 1977 [4] . The cardinal features of EDS VIII are severe and intractable periodontal inflammation, pretibial plaques with onset in childhood or adolescence, and a family history of first-degree relatives [1, 3] .
The 7 cM (5.8 MB) interval on chromosome 12q13 locus has evidence for linkage with logarithm of the odds score 5.17 for EDS VIII [5] . Genome-wide linkage scan performed in a 4-generation family with history of EDS VIII detects linked region on chromosome 9 [6] . However, any candidate gene in these regions has not been identified [5, 6] . In a recent report, heterozygous variants of the C1R (OMIM 613785) or C1S (OMIM 120580) located on 12p13 related to the classical complement pathway were identified in 17 families with history of EDS VIII (98 individuals) using whole exome sequencing [7] .
The current report describes a Korean female carrying a novel missense variant of C1R exhibiting early severe periodontitis, skin fragility, and joint hypermobility. Of note, she had multifocal white matter brain lesions, which have not been surveyed meticulously in EDS VIII [8] .
Case
A 34-year-old female came to the Asan medical center rheumatologic outpatient clinic due to facial rash and abnormal findings on brain magnetic resonance imaging (MRI), which was done for the evaluation of general fatigue and intermittent headaches. Neurological examinations of the motor and sensory nervous system and cranial nerves had normal results. She had taken thyroid hormone for 10 years due to hypothyroidism and received extracorporeal shock wave lithotripsy 3 times due to left renal stone. She smoked one pack of cigarettes a day for five years. Brain MRI showed bilateral patchy T2-weight high-signal intensity lesions in frontal, parietal, and temporal white matter without definite vascular abnormalities (Fig. 1A ). Brain magnetic resonance angiography showed no definite vascular abnormalities (Fig. 1B) . Laboratory studies to rule out vasculitis associated with autoimmune diseases showed antinuclear antibody, antineutrophil cytoplasmic antibody, cryoglobulin, rheumatoid factor, anti-Sjögren's syndrome A , anti-Sjögren's syndrome B, antithyroid peroxidase antibody, thyroid function, complete blood count, and coagulation profile to be normal.
The patient was referred to the medical genetics clinic due to suspicion of connective tissue disorders because her legs were susceptible to bruising and recovery had been slow since early childhood. Physical examination revealed marked skin fragility with easy bruising, brownish hyperpigmentation of both shins ( Fig. 2A) , facial rash, and skin hyperextensibility. She showed hypermobility of both the elbow and knee joints, and the Beighton score was 5. She was diagnosed with periodontitis at the age of 20. Since then, she has been suffering from recurrent periodontal infections and has begun to lose her teeth. To date, she has lost most of her teeth except for six molars (Fig. 2B) , which have been replaced by artificial teeth. She had no dysmorphism including triangular facial structure, prominent eyes, and a long nose. Her voice was hoarse. The patient recalled that her mother had lost all of her teeth by her early 20s and also had pretibial bruising. She ultimately died of gastric adenocarcinoma at the age of 40 years. Her youngest maternal uncle also suffered from periodontal problems, and her younger brother had lost all of his teeth by his early 30s and showed pretibial bruising (Fig. 2C) .
Informed consent was obtained, and blood sample was collected from the patient. Genomic DNA was extracted from peripheral blood leukocytes using a Puregene DNA isolation kit (Gentra, Minneapolis, MN, USA). All coding 11 exons and exonintron boundaries of C1R were directly sequenced using an ABI 3130 genetic analyzer (Applied Biosystems, Foster City, CA, USA) and a BigDye Terminator cycle sequencing kit (Applied Biosystems) in peripheral leukocytes. A previously unknown germ line variant, c.925T>G (p.Cys309Gly), was identified in the C1R (Fig.  3) . The variant p.Cys309Gly, which has not been reported in the general population (http://gnomad.broadinstitute.org/about), was predicted to be pathogenic by in silico prediction programs such as a PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/) score of 1 and Sorting Intolerant from Tolerant (http://sift.jcvi. org/) score of 0. This variant is classified as likely to be pathogenic according to the American College of Medical Genetics and Genomics guideline [9] .
After the confirmation of the diagnosis of EDS VIII, echocardiography was done in order to check for vascular and cardiac problems and gave normal results. Smoking cessation and regular dental examination were recommended for the care of periodontitis.
Discussion
More than 90% of patients with EDS VIII exhibit early severe periodontitis, gingival recession, absence of attached gingiva, and easy bruising [7] . Pretibial hyperpigmentation, skin fragility, and elastic skin are also common, and abnormal scarring, joint hypermobility, recurrent infection, and marfanoid facial features may be observed [3, 7, 10] . Rarely, autoimmune disorder, organ rupture, osteoarthritis, hoarseness, and joint dislocation were also reported in EDS VIII [7, 11] . EDS VIII can be suspected based on these distinctive clinical features [3] [4] [5] [6] 10, 11] . The patient described in the current report exhibited these distinct features via dominant inheritance from her mother as well as atypical feature such as hoarse voice.
The pathogenic mechanism of EDS VIII has thus far been elusive. However, considering that the genetic defect of EDS VIII resides in the first component of the classical complement path- way, C1 complex [7] , its pathologic features might be associated with abnormal activity of the complement cascade. Binding of recognition subunit (C1q) to a pathogen triggers self-activation of C1r, which in turn activates C1s that cleaves complement components C2 and C4, thereby initiating the complement cascade [12] . Kapferer-Seebacher et al. [7] reported that C1R pathogenic variants such as p.Cys309Trp, p.Cys338Arg, p.Cys358Phe, and p.Cys371Trp disrupt the paired cysteine residues involved in disulfide bonds that are important in stabilizing the catalytic and interaction domain of C1R, resulting in morphological changes in the rough endoplasmic reticulum. Thus, mutated C1R is expected to alter the target specificity of the C1 complex. In the current case, a novel missense variant (p.Cys309Gly) was found, in the same residue of the previously reported variant (p.Cys309Trp) [7] . Although we did not perform in vivo or in vitro functional studies on the current patient, we expect p.Cys309Gly to be pathogenic based on the location of the residue, population data, and in silico analysis.
To our knowledge, multiple white matter lesions in the brain have only been reported in one other case of EDS VIII, which was not genetically confirmed [8] . On the other hand, brain inflammation due to abnormal activation of complement pathway has been observed in other more common demyelinating or neurodegenerative diseases such as Alzheimer disease and multiple sclerosis. In Alzheimer disease, the fibrillar amyloid plaques lead to complement activation, subsequently causing an acceleration of local inflammation and neuronal injuries [13] . In the type II pattern of multiple sclerosis, complements and autoantibodies contribute to demyelination by complement activation in the blood vessels of white matter [14] . Thus, the brain abnormalities in EDS VIII might be associated with the alteration of complement and collagen processing. Further molecular and in vivo evidence is needed to validate this association between altered complement activity and brain lesions. Although there was no definite neurological symptom in the current patient, long-term observation is warranted for the development of neurological manifestation. As brain abnormalities have not been surveyed in EDS VIII, further evaluation of neurological manifestations with brain imaging studies would be necessary for more patients with EDS VIII.
